Bio Essence Corp (BIOE) stock
BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.42+0.03 (+7.72%)
Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –
Bio Essence r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Bio Essence
Bio Essence has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?